Beta Bionics Share Price (NASDAQ: BBNX)

$18.84

▲

0.13

(0.69%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Beta Bionics Stock chart to analyse performance

Beta Bionics stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$18.16
Today's High:$19.11
$18.84
3.61%
Downside
Day's Volatility :4.97%
Upside
1.41%
52 Weeks Low:$8.89
52 Weeks High:$24.50
$18.84
52.81%
Downside
52 Weeks Volatility :63.71%
Upside
23.1%

Beta Bionics Stock Returns

Period	Beta Bionics Inc.	Index (Russel 2000)
3 Months	0.78%	0.0%
6 Months	-10.22%	0.0%
1 Year	-20.29%	0.0%
3 Years	-20.29%	-4.1%

Beta Bionics Inc. Key Stats

Check Beta Bionics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$18.71
Open	$18.77
Today's High	$19.11
Today's Low	$18.16
Market Capitalization	$945.1M
Today's Volume	$385.1K
52 Week High	$24.5
52 Week Low	$8.89
Revenue TTM	$53.0M
EBITDA	$-39.4M
Earnings Per Share (EPS)	$-1.3
Profit Margin	-104.64%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

Stock Returns calculator for Beta Bionics Stock including INR - Dollar returns

The Beta Bionics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Beta Bionics investment value today

Current value as on today

₹85,013

Returns

₹14,987

(-14.99%)

Returns from Beta Bionics Stock

₹20,271 (-20.27%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Beta Bionics Stock

-47%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Beta Bionics Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Beta Bionics Stock

Rating

Trend

Beta Bionics Stock Insights

Price Movement
In the last 7 days, BBNX stock has moved up by 10.5%

Beta Bionics Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY22

FY23

FY24

	FY22	Y/Y Change
Revenue	$179.0K	-
Net Income	$-64.8M	-
Net Profit Margin	-36.2K%	-

	FY23	Y/Y Change
Revenue	$12.0M	↑ 6601.12%
Net Income	$-44.1M	↓ 31.89%
Net Profit Margin	-367.64%	↑ 35806.1%

	FY24	Y/Y Change
Revenue	$65.1M	↑ 442.93%
Net Income	$-54.8M	↑ 24.17%
Net Profit Margin	-84.08%	↑ 283.56%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$12.9M	↑ 54.89%
Net Income	$-12.4M	↓ 33.95%
Net Profit Margin	-96.26%	↑ 129.46%

	Q2 FY24	Q/Q Change
Revenue	$15.0M	↑ 16.34%
Net Income	$-14.5M	↑ 16.18%
Net Profit Margin	-96.13%	↑ 0.13%

	Q3 FY24	Q/Q Change
Revenue	$16.7M	↑ 11.03%
Net Income	$-9.7M	↓ 32.68%
Net Profit Margin	-58.28%	↑ 37.85%

	Q4 FY24	Q/Q Change
Revenue	$20.4M	↑ 22.36%
Net Income	$-18.1M	↑ 85.99%
Net Profit Margin	-88.59%	↓ 30.31%

	Q1 FY25	Q/Q Change
Revenue	$17.6M	↓ 13.7%
Net Income	$-28.7M	↑ 58.25%
Net Profit Margin	-162.46%	↓ 73.87%

	Q2 FY25	Q/Q Change
Revenue	$23.2M	↑ 31.74%
Net Income	$-16.9M	↓ 41.13%
Net Profit Margin	-72.59%	↑ 89.87%

FY22

FY23

FY24

	FY22	Y/Y Change
Profit	$179.0K	-

	FY23	Y/Y Change
Profit	$6.3M	↑ 3424.02%

	FY24	Y/Y Change
Profit	$35.9M	↑ 468.93%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$7.2M	↑ 42.26%

	Q2 FY24	Q/Q Change
Profit	$8.1M	↑ 12.26%

	Q3 FY24	Q/Q Change
Profit	$8.9M	↑ 10.27%

	Q4 FY24	Q/Q Change
Profit	$11.7M	↑ 31.13%

	Q1 FY25	Q/Q Change
Profit	$9.0M	↓ 23.25%

	Q2 FY25	Q/Q Change
Profit	$12.5M	↑ 39.37%

FY22

FY23

FY24

	FY22	Y/Y Change
Operating Cash Flow	$-60.2M	-
Investing Cash Flow	$-769.0K	-
Financing Cash Flow	$56.8M	-

	FY23	Y/Y Change
Operating Cash Flow	$-32.4M	↓ 46.11%
Investing Cash Flow	$-69.7M	↑ 8962.81%
Financing Cash Flow	$101.0M	↑ 77.92%

	FY24	Y/Y Change
Operating Cash Flow	$-48.3M	↑ 48.78%
Investing Cash Flow	$-3.5M	↓ 95.01%
Financing Cash Flow	$55.6M	↓ 44.95%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-12.1M	↑ 91.33%
Investing Cash Flow	$7.6M	↓ 110.98%
Financing Cash Flow	$6.0K	↓ 33.33%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-12.2M	↑ 0.77%
Investing Cash Flow	$3.3M	↓ 56.83%
Financing Cash Flow	$-107.0K	↓ 1883.33%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-9.6M	↓ 21.44%
Investing Cash Flow	$15.2M	↑ 361.88%
Financing Cash Flow	$-1.2M	↑ 999.07%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-14.3M	↑ 48.54%
Investing Cash Flow	$-29.7M	↓ 294.61%
Financing Cash Flow	$56.9M	↓ 4937.76%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-20.0M	↑ 39.89%
Investing Cash Flow	$-179.1M	↑ 503.88%
Financing Cash Flow	$211.1M	↑ 271.09%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-13.6M	↓ 31.94%
Investing Cash Flow	$6.2M	↓ 103.45%
Financing Cash Flow	$42.0K	↓ 99.98%

Beta Bionics Technicals Summary

Sell

Neutral

Buy

Beta Bionics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Beta Bionics Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Beta Bionics Inc.	14.85%	-10.22%	-20.29%	-20.29%	-20.29%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	4.24%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Beta Bionics Inc.	NA	NA	NA	0.0	0.0	0.0	NA	-34.35
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Beta Bionics Inc.	NA	$945.1M	-20.29%	NA	-104.64%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Beta Bionics Inc.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.

Organization	Beta Bionics
Employees	387
CEO	Mr. Sean T. Saint PE
Industry	Miscellaneous

Key Management of Beta Bionics Inc.

Name	Title
Mr. Sean T. Saint PE	President, CEO & Director
Mr. Stephen H. Feider	CFO, Treasurer & Secretary
Mr. Mark Hopman M.B.A., R.Ph.	Chief Commercial Officer
Mr. David Henderson	Vice President of Operations
Blake Beber	Head of Investor Relations
Mr. Kevin Meinert	Vice President of Legal & Business Development
Ms. Karen Hynes M.B.A.	Vice President of Marketing Execution
Dr. Steven Russell M.D., Ph.D.	Chief Medical Officer
Mr. Mike Mensinger	Chief Product Officer

Important FAQs about investing in BBNX Stock from India :

What is Beta Bionics share price today?

Beta Bionics share price today is $18.84 as on August 30, 2025 at 1:29 am IST at the close of the market. Beta Bionics share today touched a day high of $19.11 and a low of $18.16.

What is the 52 week high and 52 week low for Beta Bionics share?

Beta Bionics share touched a 52 week high of $24.50 and a 52 week low of $8.89. Beta Bionics stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $18.84, lower by 23.1% versus the 52 week high.

How to invest in Beta Bionics Stock (BBNX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Beta Bionics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Beta Bionics Shares that will get you 0.0796 shares as per Beta Bionics share price of $18.84 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Beta Bionics Stock (BBNX) from India?

Indian investors can start investing in Beta Bionics (BBNX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Beta Bionics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Beta Bionics share’s latest price of $18.84 as on August 30, 2025 at 1:29 am IST, you will get 0.5308 shares of Beta Bionics. Learn more about fractional shares .

What are the returns that Beta Bionics has given to Indian investors in the last 5 years?

Beta Bionics stock has given -20.29% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?